RE:TFC-1067 and SGLT2Co. stopped using skin lightening descriptor because of trial results....
TFC1067 and 2% hydroquinone produced statistically significant skin lightening after 8 weeks of use, but only hydroquinone lightened the normal skin. https://onlinelibrary.wiley.com/doi/10.1111/jocd.13771 forhandlaren wrote: I recall that Howard stated R+F product release 15-18 months after the signed deal, check out video interview during summer '19.
That would translate to Q1'21. Considering the ongoing compound production at two different sites it would be possible. Let's hope for the best.
I agree that the company quietly has changed the TFC-1067 from Skin Lightener in the broad sense to a more narrow dark spot lightener. Not sure why.
Seems like the same compound, otherwise I would bet on multiple compounds with different properties/effects.
If different I'd say they just follow the changed sentiment on the market. Don't think it is as politically correct as before to market lighter skin.
I'm actually not very happy about the lightening in order to strive for this cultural ideal, but when bad and dangerous treatments could be replaced with a safe one - and the market would persist anyway - I'm all for it.
The next news seems to be SGLT2 for pets. Does anyone know how the difference in scientific steps/requirements between human och pet meds?